Group X secretory phospholipase A2 enhances TLR4 signaling in macrophages

Journal of Immunology

Volumn 187, Issue 1, 2011, Pages 482-489

  Shridas, Preetha ^a,b   Bailey, William M ^a,b   Talbott, Kayla R ^a   Oslund, Rob C ^c   Gelb, Michael H ^c   Webb, Nancy R ^a,b  

^a UNIVERSITY OF KENTUCKY MEDICAL CENTER   (United States)

^b LEXINGTON VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; CYCLODEXTRIN; CYCLOOXYGENASE 2; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHOLIPASE A2 GROUP X; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; ENZYME ACTIVITY; INFLAMMATION; LIPID RAFT; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; CELL LINE; CHOLESTEROL; FEMALE; GROUP X PHOSPHOLIPASES A2; HOMEOSTASIS; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MEMBRANE MICRODOMAINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 79960413123     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1003552     Document Type: Article

References (41)

1. Glass, C. K., and J. L. Witztum. 2001. Atherosclerosis. the road ahead. Cell 104: 503-516.
2. Lusis, A. J. 2000. Atherosclerosis. Nature 407: 233-241.
3. Li, Y., R. F. Schwabe, T. DeVries-Seimon, P. M. Yao, M. C. Gerbod-Giannone, A. R. Tall, R. J. Davis, R. Flavell, D. A. Brenner, and I. Tabas. 2005. Free cholesterol-loaded macrophages are an abundant source of tumor necrosis factor-alpha and interleukin-6: model of NF-kappaB- and map kinase-dependent inflammation in advanced atherosclerosis. J. Biol. Chem. 280: 21763-21772.
4. Zhu, X., J. Y. Lee, J. M. Timmins, J. M. Brown, E. Boudyguina, A. Mulya, A. K. Gebre, M. C. Willingham, E. M. Hiltbold, N. Mishra, et al. 2008. Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages. J. Biol. Chem. 283: 22930-22941.
5. Yvan-Charvet, L., C. Welch, T. A. Pagler, M. Ranalletta, M. Lamkanfi, S. Han, M. Ishibashi, R. Li, N. Wang, and A. R. Tall. 2008. Increased inflammatory gene expression in ABC transporter-deficient macrophages: free cholesterol accumulation, increased signaling via toll-like receptors, and neutrophil infiltration of atherosclerotic lesions. Circulation 118: 1837-1847.
6. 2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J. Biol. Chem. 275: 3179-3191.
7. 2 in human lung macrophages expressing the M-type receptor. J. Immunol. 174: 464-474.
8. 2 group X enhances anti-inflammatory responses, promotes lipid accumulation, and contributes to aberrant lung pathology. J. Biol. Chem. 283: 21640-21648.
9. 2 group X overexpression in asthma and bronchial hyperresponsiveness. Am. J. Respir. Crit. Care Med. 176: 1072-1078.
10. 2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J. Exp. Med. 204: 865-877.
11. 2-deficient mice. Circulation 117: 2977-2985.
12. 2. J. Immunol. 184: 5232-5241.
13. 2 negatively regulates ABCA1 and ABCG1 expression and cholesterol efflux in macrophages. Arterioscler. Thromb. Vasc. Biol. 30: 2014-2021.
14. Michelsen, K. S., T. M. Doherty, P. K. Shah, and M. Arditi. 2004. TLR signaling: an emerging bridge from innate immunity to atherogenesis. J. Immunol. 173: 5901-5907. (Pubitemid 39487741)
15. Shridas, P., W. M. Bailey, B. B. Boyanovsky, R. C. Oslund, M. H. Gelb, and N. R. Webb. 2010. Group X secretory phospholipase A2 regulates the expression of steroidogenic acute regulatory protein (StAR) in mouse adrenal glands. J. Biol. Chem. 285: 20031-20039.
16. Björkbacka, H., V. V. Kunjathoor, K. J. Moore, S. Koehn, C. M. Ordija, M. A. Lee, T. Means, K. Halmen, A. D. Luster, D. T. Golenbock, and M. W. Freeman. 2004. Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways. Nat. Med. 10: 416-421.
17. 2-modified LDL. J. Lipid Res. 50: 641-650.
18. 2 inhibitors are also potent blockers of binding to the M-type receptor. Biochemistry 45: 13203-13218.
19. 2 is linked to macrophage foam cell formation. J. Biol. Chem. 277: 29116-29124.
20. Takeda, K., and S. Akira. 2004. TLR signaling pathways. Semin. Immunol. 16: 3-9.
21. Carpenter, S., and L. A. O'Neill. 2009. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem. J. 422: 1-10.
22. Michelsen, K. S., M. H. Wong, P. K. Shah, W. Zhang, J. Yano, T. M. Doherty, S. Akira, T. B. Rajavashisth, and M. Arditi. 2004. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl. Acad. Sci. USA 101: 10679-10684.
23. Kay, J. G., R. Z. Murray, J. K. Pagan, and J. L. Stow. 2006. Cytokine secretion via cholesterol-rich lipid raft-associated SNAREs at the phagocytic cup. J. Biol. Chem. 281: 11949-11954.
24. Koseki, M., K. Hirano, D. Masuda, C. Ikegami, M. Tanaka, A. Ota, J. C. Sandoval, Y. Nakagawa-Toyama, S. B. Sato, T. Kobayashi, et al. 2007. Increased lipid rafts and accelerated lipopolysaccharide-induced tumor necrosis factor-alpha secretion in Abca1-deficient macrophages. J. Lipid Res. 48: 299-306. (Pubitemid 46220596)
25. Olsson, S., and R. Sundler. 2006. The role of lipid rafts in LPS-induced signaling in a macrophage cell line. Mol. Immunol. 43: 607-612.
26. Triantafilou, M., K. Miyake, D. T. Golenbock, and K. Triantafilou. 2002. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 115: 2603-2611. (Pubitemid 34778077)
27. Morales-García, M. G., J. J. Fournié, M. B. Moreno-Altamirano, G. Rodríguez-Luna, R. M. Flores, and F. J. Sánchez-García. 2008. A flow-cytometry method for analyzing the composition of membrane rafts. Cytometry A 73: 918-925.
28. Christian, A. E., M. P. Haynes, M. C. Phillips, and G. H. Rothblat. 1997. Use of cyclodextrins for manipulating cellular cholesterol content. J. Lipid Res. 38: 2264-2272.
29. Steinberg, D. 2002. Atherogenesis in perspective: hypercholesterolemia and inflammation as partners in crime. Nat. Med. 8: 1211-1217.
30. Ishimoto, Y., K. Yamada, S. Yamamoto, T. Ono, M. Notoya, and K. Hanasaki. 2003. Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Biochim. Biophys. Acta 1642: 129-138.
31. 2. Biochim. Biophys. Acta 1761: 1093-1099.
32. Bates, S. R., J.-Q. Tao, H. L. Collins, O. L. Francone, and G. H. Rothblat. 2005. Pulmonary abnormalities due to ABCA1 deficiency in mice. Am. J. Physiol. Lung Cell. Mol. Physiol. 289: L980-L989.
33. Yancey, P. G., W. V. Rodrigueza, E. P. Kilsdonk, G. W. Stoudt, W. J. Johnson, M. C. Phillips, and G. H. Rothblat. 1996. Cellular cholesterol efflux mediated by cyclodextrins. Demonstration of kinetic pools and mechanism of efflux. J. Biol. Chem. 271: 16026-16034.
34. Zelcer, N., and P. Tontonoz. 2006. Liver X receptors as integrators of metabolic and inflammatory signaling. J. Clin. Invest. 116: 607-614.
35. Castrillo, A., and P. Tontonoz. 2004. Nuclear receptors in macrophage biology: At the crossroads of lipid metabolism and inflammation. Annu. Rev. Cell Dev. Biol. 20: 455-480.
36. Joseph, S. B., A. Castrillo, B. A. Laffitte, D. J. Mangelsdorf, and P. Tontonoz. 2003. Reciprocal regulation of inflammation and lipid metabolism by liver X receptors. Nat. Med. 9: 213-219.
37. 2) as a natural ligand for mouse phospholipase A(2) receptor. FEBS Lett. 478: 187-191.
38. 2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model. Exp. Lung Res. 36: 191-200.
39. 2) augments angiotensin II-induced inflammatory responses and abdominal aortic aneurysm formation in apoE-deficient mice. Atherosclerosis 214: 58-64.
40. 2 receptor. Arch. Biochem. Biophys. 381: 31-42.
41. 2 in mice leads to neonatal lethality because of lung dysfunction. J. Biol. Chem. 281: 36420-36433.